Search all trials

Find therapies in clinical trials near you – page 15

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Smoking cessation therapy+1

Recruiting

Registered drug

Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Cytisine

Contact Research Centre

Coronary artery disease

Recruiting

Registered drugNo placebo

Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

Registered drugNo placebo

Finland

Participants:18–64 years · 65+ years
Substances:Adenosine

Contact Research Centre

Hepatic fibrosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Sjogren's syndrome

Recruiting

Investigational

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Deucravacitinib

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Venetoclax

Contact Research Centre

Coronary artery disease

Recruiting

Registered drugNo placebo

Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Adenosine

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Favezelimab

Contact Research Centre

Arteriosclerosis

Recruiting

Investigational

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Investigational

Austria

Participants:18–64 years · 65+ years
Substances:Clazakizumab

Contact Research Centre

Atrial fibrillation

Recruiting

Investigational

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational

Bulgaria

Participants:65+ years
Substances:Abelacimab

Contact Research Centre

Hepatic cirrhosis+2

Recruiting

Investigational

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Efruxifermin

Contact Research Centre

Amyotrophic lateral sclerosis

Recruiting

Investigational

Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:Dazucorilant

Contact Research Centre

Schizophrenia

Recruiting

Investigational

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Investigational

Bulgaria

Participants:18–64 years
Substances:Vafidemstat

Contact Research Centre

Find therapies in clinical trials near you – page 15

3 962 trials match your criteria

Smoking cessation therapy+1

Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

Coronary artery disease

Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

Hepatic fibrosis+2

Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Sjogren's syndrome

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Acute myeloid leukaemia

Study on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure

Coronary artery disease

Study on Coronary Artery Disease: Evaluating Myocardial Blood Flow Using SYN2, Regadenoson, and Adenosine in Patients with Heart Conditions

Neoplasm malignant

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Arteriosclerosis

Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis

Atrial fibrillation

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Hepatic cirrhosis+2

Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Amyotrophic lateral sclerosis

Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

Schizophrenia

Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.